Reproductive Health News

Black women tend to prefer to be cared for by Black obstetric providers during pregnancy due to past experiences of discrimination and racism, according to a presenter at The Pregnancy Meeting.

Current data support naltrexone use as medication for opioid use disorder in pregnancy, with encouraging perinatal outcomes, according to a systematic review published in Obstetrics & Gynecology.

U.S. policy changes are needed to reduce perinatal mental health deserts, standardize social determinants of health data, improve psychiatric curriculums and establish paid parental leave, researchers reported in JAMA Psychiatry.

Pregnant women who were prescribed opioid drugs had increased likelihood of spontaneous preterm delivery, and odds increased as total dose increased, according to case-control study results published in JAMA Network Open.

A new at-home menopause test hit the market last fall, promising women the ability to accurately measure a hormone associated with menopause stage and predict how close they might be to their final menstrual period.

In this video exclusive, Caroline T. Nguyen, MD, talks with Nicole Gomez, MD, about implications of prediabetes in pregnancy.

SCOTTSDALE, Ariz. — A novel therapeutic approach targeting the neonatal fragment crystallizable receptor may have implications across a number of rheumatology disease states, according to a speaker.

Polycystic ovary syndrome was associated with increased risk for CVD in women, and while incidence varies, its prevalence worldwide increased since 1990, researchers reported.

Dexmedetomidine administration early in the postpartum period was associated with significantly lower positive postpartum depression incidence compared with placebo, researchers reported in JAMA Network Open.

In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.